Skin lipids and epidermal differentiation in atopic dermatitis

Clinics in Dermatology

Volumn 21, Issue 2, 2003, Pages 134-144

  Proksch, Ehrhardt ^a   Jensen, Jens Michael ^b   Elias, Peter M ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CERAMIDE; CHOLESTEROL SULFATE; CORTICOSTEROID; CYCLOSPORIN; FATTY ACID; FILAGGRIN; INVOLUCRIN; ISOPROTEIN; PROSAPOSIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SKIN LIPID; SPHINGOMYELIN; TACROLIMUS; WATER;

ATOPIC DERMATITIS; CAT; CLIMATE; DERMATOPHAGOIDES PTERONYSSINUS; DRY SKIN; ECZEMA; ENZYME ACTIVITY; EPIDERMIS; FATTY ACID METABOLISM; GENETIC DISORDER; GRASS POLLEN; HUMAN; LIFESTYLE; LIPOGENESIS; MENTAL STRESS; PATCH TEST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKIN FUNCTION; SKIN MANIFESTATION; SKIN WATER LOSS; STRATUM CORNEUM; TREATMENT OUTCOME; WATER CONTENT;

EID: 0037357652     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00370-X     Document Type: Review

References (125)

1. Bos J.D., Kapsenberg M.L., Smitt J.H. Pathogenesis of atopic eczema. Lancet. 343:1994;1338-1341.
2. Ghadially R., Halkier-Sorensen L., Elias P.M. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol. 26:1992;387-396.
3. Yoshiike T., Aikawa Y., Sindhvananda J., et al. Skin barrier defect in atopic dermatitis increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline . J Dermatol Sci. 5:1993;92-96.
4. Shahidullah M., Raffle E.J., Rimmer A.R., Frain-Bell W. Transepidermal water loss in patients with dermatitis. Br J Dermatol. 81:1969;722-730.
5. Agner T. Noninvasive measuring methods for the investigation of irritant patch test reactions. A study of patients with hand eczema, atopic dermatitis and controls. Acta Derm Venereol. 173(Suppl):1992;1-26.
6. Seidenari S., Giusti G. Objective assessment of the skin of children affected by atopic dermatitis a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin . Acta Derm Venereol. 75:1995;429-433.
7. Denda M., Wood L.C., Emami S., et al. The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res. 288:1996;230-238.
8. Matsumoto M., Sugiura H., Uehara M. Skin barrier function in patients with completely healed atopic dermatitis. J Dermatol Sci. 23:2000;178-182.
9. Elias P.M., Menon G.K. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 24:1991;1-26.
10. Lee S.H., Elias P.M., Proksch E., et al. Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest. 89:1992;530-538.
11. + gradients in murine epidermis quantitative measurement using PIXE . J Invest Dermatol. 111:1998;1198-1201.
12. Mauro T., Holleran W.M., Grayson S., et al. Barrier recovery is impeded at neutral pH, independent of ionic effects implications for extracellular lipid processing . Arch Dermatol Res. 290:1998;215-222.
13. Wertz P.W., Swartzendruber D.C., Kitko D.J., et al. The role of the corneocyte lipid envelopes in cohesion of the stratum corneum. J Invest Dermatol. 93:1989;169-172.
14. Ekanayake-Mudiyanselage S., Aschauer H., Schmook F.P., et al. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J Invest Dermatol. 111:1998;517-523.
15. Marekov L.N., Steinert P.M. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem. 273:1998;17763-17770.
16. Rassner U., Feingold K.R., Crumrine D.A., Elias P.M. Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies. Tissue Cell. 31:1999;489-498.
17. Jensen J.M., Schutze S., Neumann C., Proksch E. Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice. J Invest Dermatol. 115:2000;708-713.
18. Schurer N.Y., Elias P.M. The biochemistry and function of stratum corneum lipids. Adv Lipid Res. 24:1991;27-56.
19. Robson K.J., Stewart M.E., Michelsen S., et al. 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res. 35:1994;2060-2068.
20. Schmuth M., Man M.Q., Weber F., et al. Permeability barrier disorder in Niemann-Pick disease sphingomyelin-ceramide processing required for normal barrier homeostasis . J Invest Dermatol. 115:2000;459-466.
21. Holleran W.M., Man M.Q., Gao W.N., et al. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest. 88:1991;1338-1345.
22. Holleran W.M., Takagi Y., Menon G.K., et al. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest. 91:1993;1656-1664.
23. Holleran W.M., Takagi Y., Menon G.K., et al. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res. 35:1994;905-912.
24. Jensen J.M., Schutze S., Forl M., et al. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest. 104:1999;1761-1770.
25. Behne M., Uchida Y., Seki T., et al. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol. 114:2000;185-192.
26. Wertz P.W., Cho E.S., Downing D.T. Effect of essential fatty acid deficiency on the epidermal sphingolipids of the rat. Biochim Biophys Acta. 753:1983;350-355.
27. Wertz P.W., Swartzendruber D.C., Abraham W., et al. Essential fatty acids and epidermal integrity. Arch Dermatol. 123:1987;1381-1384.
28. Elias P.M., Brown B.E. The mammalian cutaneous permeability barrier defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition . Lab Invest. 39:1978;574-583.
29. Bouwstra J.A., Gooris G.S., Dubbelaar F.E., et al. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res. 39:1998;186-196.
30. Wertz P.W., Downing D.T. Covalent attachment of omega-hydroxyacid derivatives to epidermal macromolecules a preliminary characterization . Biochem Biophys Res Commun. 137:1986;992-997.
31. Nemes Z., Marekov L.N., Steinert P.M. Involucrin cross-linking by transglutaminase 1. Binding to membranes directs residue specificity. J Biol Chem. 274:1999;11013-11021.
32. Feingold K.R. The regulation and role of epidermal lipid synthesis. Adv Lipid Res. 24:1991;57-82.
33. Elias P.M., Ansel J.C., Woods L.D., Feingold K.R. Signaling networks in barrier homeostasis. The mystery widens. Arch Dermatol. 132:1996;1505-1506.
34. Elias P.M. Stratum corneum architecture, metabolic activity and interactivity with subjacent cell layers. Exp Dermatol. 5:1996;191-201.
35. Elias P.M., Wood L.C., Feingold K.R. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat. 10:1999;119-126.
36. Grubauer G., Feingold K.R., Elias P.M. Relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res. 28:1987;746-752.
37. Menon G.K., Feingold K.R., Elias P.M. Lamellar body secretory response to barrier disruption. J Invest Dermatol. 98:1992;279-289.
38. Menon G.K., Grayson S., Elias P.M. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol. 86:1986;591-597.
39. Grubauer G., Elias P.M., Feingold K.R. Transepidermal water loss the signal for recovery of barrier structure and function . J Lipid Res. 30:1989;323-333.
40. Proksch E., Feingold K.R., Elias P.M. Epidermal HMG CoA reductase activity in essential fatty acid deficiency barrier requirements rather than eicosanoid generation regulate cholesterol synthesis . J Invest Dermatol. 99:1992;216-220.
41. Holleran W.M., Gao W.N., Feingold K.R., Elias P.M. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity alterations imposed by permeability barrier requirements . Arch Dermatol Res. 287:1995;254-258.
42. Uchida Y., Hara M., Nishio H., et al. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res. 41:2000;2071-2082.
43. Proksch E., Feingold K.R., Man M.Q., Elias P.M. Barrier function regulates epidermal DNA synthesis. J Clin Invest. 87:1991;1668-1673.
44. Jakobza D., Reichmann G., Langnick W., et al. Surface skin lipids in atopic dermatitis [author's transl]. Dermatol Monatsschr. 167:1981;26-29.
45. Barth J., Gatti S., Jatzke M. Skin surface lipids in atopic eczema and ichthyosis. Chron Derm. 10:1989;609-612.
46. Mustakallio K.K., Kiistala U., Piha H.J., Nieminen E. Epidermal lipids in Besnier's prurigo (atopic eczema). Ann Med Exp Biol Fenn. 45:1967;323-325.
47. Schafer L., Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol. 96:1991;10-15.
48. Melnik B., Hollmann J., Plewig G. Decreased stratum corneum ceramides in atopic individuals - a pathobiochemical factor in xerosis? Br J Dermatol. 119:1988;547-549.
49. Melnik B.C., Hollmann J., Erler E., et al. Microanalytical screening of all major stratum corneum lipids by sequential high-performance thin-layer chromatography. J Invest Dermatol. 92:1989;231-234.
50. Imokawa G., Abe A., Jin K., et al. Decreased level of ceramides in stratum corneum of atopic dermatitis an etiologic factor in atopic dry skin? J Invest Dermatol. 96:1991;523-526.
51. Yamamoto A., Serizawa S., Ito M., Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res. 283:1991;219-223.
52. Matsumoto Y., Hamashima H., Masuda K., et al. The antibacterial activity of plaunotol against Staphylococcus aureus isolated from the skin of patients with atopic dermatitis. Microbios. 96:1998;149-155.
53. Di Nardo A., Wertz P., Giannetti A., Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 78:1998;27-30.
54. Bleck O., Abeck D., Ring J., et al. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol. 113:1999;894-900.
55. Jin K., Higaki Y., Takagi Y., et al. Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol. 74:1994;337-340.
56. Redoules D., Tarroux R., Assalit M.F., Peri J.J. Characterisation and assay of five enzymatic activities in the stratum corneum using tape-strippings. Skin Pharmacol Appl Skin Physiol. 12:1999;182-192.
57. Doering T., Holleran W.M., Potratz A., et al. Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem. 274:1999;11038-11045.
58. Cui C.Y., Kusuda S., Seguchi T., et al. Decreased level of prosaposin in atopic skin. J Invest Dermatol. 109:1997;319-323.
59. Kreder D., Krut O., Adam-Klages S., et al. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18:1999;2472-2479.
60. Kusuda S., Cui C.Y., Takahashi M., Tezuka T. Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol. 111:1998;733-738.
61. Proksch E., Baranowski A., Jensen J.M., et al. Decreased activity of membrane bound neutral sphingomyelinase correlates with impaired epidermal differentiation in atopic dermatitis. Arch Dermatol Res. 294:2002;45.
62. Murata Y., Ogata J., Higaki Y., et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis an etiologic factor for ceramide deficiency? J Invest Dermatol. 106:1996;1242-1249.
63. Hara J., Higuchi K., Okamoto R., et al. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol. 115:2000;406-413.
64. Higuchi K., Hara J., Okamoto R., et al. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J. 350:(Pt 3):2000;747-756.
65. Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol. 45:(Suppl):2001;S29-32.
66. Ohnishi Y., Okino N., Ito M., Imayama S. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol. 6:1999;101-104.
67. Fartasch M., Diepgen T.L. The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids? Acta Derm Venereol Suppl. 176:1992;26-31.
68. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound ω-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002;119(1):166-73.
69. Hou S.Y., Mitra A.K., White S.H., et al. Membrane structures in normal and essential fatty acid-deficient stratum corneum characterization by ruthenium tetroxide staining and x-ray diffraction . J Invest Dermatol. 96:1991;215-223.
70. Melton J.L., Wertz P.W., Swartzendruber D.C., Downing D.T. Effects of essential fatty acid deficiency on epidermal O-acylsphingolipids and transepidermal water loss in young pigs. Biochim Biophys Acta. 921:1987;191-197.
71. Bibel D.J., Miller S.J., Brown B.E., et al. Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol. 92:1989;632-638.
72. Horrobin D.F. Essential fatty acid metabolism and its modification in atopic eczema. Am J Clin Nutr. 71:(Suppl):2000;367S-372S.
73. Melnik B.C., Plewig G. Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1? J Am Acad Dermatol. 21:1989;557-563.
74. Morse P.F., Horrobin D.F., Manku M.S., et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol. 121:1989;75-90.
75. Berth-Jones J., Graham-Brown R.A. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet. 341:1993;1557-1560.
76. Henz B.M., Jablonska S., van de Kerkhof P.C., et al. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol. 140:1999;685-688.
77. Burton J.L. Dietary fatty acids and inflammatory skin disease. Lancet. 1:1989;27-31.
78. Komuves L.G., Hanley K., Man M.Q., et al. Keratinocyte differentiation in hyperproliferative epidermis topical application of PPAR alpha activators restores tissue homeostasis . J Invest Dermatol. 115:2000;361-367.
79. Komuves L.G., Hanley K., Lefebvre A.M., et al. Stimulation of PPAR alpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol. 115:2000;353-360.
80. 3H-thymidine labeling) of epidermal and dermal lesions [author's transl] . Ann Dermatol Venereol. 106:1979;327-335.
81. Scott I.R., Harding C.R. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol. 115:1986;84-92.
82. Nguyen V.T., Ndoye A., Hall L.L., et al. Programmed cell death of keratinocytes culminates in apoptotic secretion of a humectant upon secretagogue action of acetylcholine. J Cell Sci. 114:2001;1189-1204.
83. Seguchi T., Cui C.Y., Kusuda S., et al. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res. 288:1996;442-446.
84. Meguro S., Arai Y., Masukawa Y., et al. Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch Dermatol Res. 292:2000;463-468.
85. Choate K.A., Williams M.L., Khavari P.A. Abnormal transglutaminase 1 expression pattern in a subset of patients with erythrodermic autosomal recessive ichthyosis. J Invest Dermatol. 110:1998;8-12.
86. Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol (Stockh). 65:1985;102-105.
87. Imokawa G. Skin moisturizers development and clinical use of ceramides . Loden M. Dry Skin and Moisturizers. 1999;269-299 CRC Press, Boca Raton, FL.
88. Imokawa G., Hattori M. A possible function of structural lipids in the water-holding properties of the stratum corneum. J Invest Dermatol. 84:1985;282-284.
89. Imokawa G., Akasaki S., Hattori M., Yoshizuka N. Selective recovery of deranged water-holding properties by stratum corneum lipids. J Invest Dermatol. 87:1986;758-761.
90. Imokawa G., Kuno H., Kawai M. Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol. 96:1991;845-851.
91. Engelke M., Jensen J.M., Ekanayake-Mudiyanselage S., Proksch E. Effects of xerosis and aging on epidermal proliferation and differentiation. Br J Dermatol. 137:1997;219-225.
92. Watanabe M., Tagami H., Horii I., et al. Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol. 127:1991;1689-1692.
93. Al-Jaberi H., Marks R. Studies of the clinically uninvolved skin in patients with dermatitis. Br J Dermatol. 111:1984;437-443.
94. Nassif A., Chan S.C., Storrs F.J., Hanifin J.M. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol. 130:1994;1402-1407.
95. Aalto-Korte K. Improvement of skin barrier function during treatment of atopic dermatitis. J Am Acad Dermatol. 33:1995;969-972.
96. Loden M., Andersson A.C., Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol. 140:1999;264-267.
97. Tabata N., O'Goshi K., Zhen Y.X., et al. Biophysical assessment of persistent effects of moisturizers after their daily applications evaluation of corneotherapy . Dermatology. 200:2000;308-313.
98. Mao-Qiang M., Brown B.E., Wu-Pong S., et al. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol. 131:1995;809-816.
99. Chamlin S.L., Frieden I.J., Fowler A., et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol. 137:2001;1110-1112.
100. Berardesca E., Barbareschi M., Veraldi S., Pimpinelli N. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis a multicenter study . Contact Dermatitis. 45:2001;280-285.
101. Ogawa H., Yoshiike T. A speculative view of atopic dermatitis barrier dysfunction in pathogenesis . J Dermatol Sci. 5:1993;197-204.
102. Nishijima T., Tokura Y., Imokawa G., et al. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol. 109:1997;175-182.
103. Adinoff A.D., Tellez P., Clark R.A. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol. 81:1988;736-742.
104. Conti A., Di Nardo A., Seidenari S. No alteration of biophysical parameters in the skin of subjects with respiratory atopy. Dermatology. 192:1996;317-320.
105. Conti A., Seidenari S. No increased skin reactivity in subjects with allergic rhinitis during the active phase of the disease. Acta Derm Venereol. 80:2000;192-195.
106. Mitchell E.B., Crow J., Chapman M.D., et al. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet. 1:1982;127-130.
107. Paganelli R., Atherton D.J., Levinsky R.J. Differences between normal and milk allergic subjects in their immune responses after milk ingestion. Arch Dis Child. 58:1983;201-206.
108. Pike M.G., Heddle R.J., Boulton P., et al. Increased intestinal permeability in atopic eczema. J Invest Dermatol. 86:1986;101-104.
109. Ukabam S.O., Mann R.J., Cooper B.T. Small intestinal permeability to sugars in patients with atopic eczema. Br J Dermatol. 110:1984;649-652.
110. Barba A., Schena D., Andreaus M.C., et al. Intestinal permeability in patients with atopic eczema. Br J Dermatol. 120:1989;71-75.
111. Ochs H.D. The Wiskott-Aldrich syndrome. Clin Rev Allergy Immunol. 20:2001;61-86.
112. Elias P.M., Wood L.C., Feingold K.R. Relationship of the epidermal permeability barrier to irritant contact dermatitis. Beltrani V. Immunology and Allergy Clinics of North America. Vol. 17:1997;417-430 Saunders, Philadelphia.
113. Garg A., Chren M.M., Sands L.P., et al. Psychological stress perturbs epidermal permeability barrier homeostasis implications for the pathogenesis of stress-associated skin disorders . Arch Dermatol. 137:2001;53-59.
114. Altemus M., Rao B., Dhabhar F.S., et al. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 117:2001;309-317.
115. McNally N.J., Williams H.C., Phillips D.R., et al. Atopic eczema and domestic water hardness. Lancet. 352:1998;527-531.
116. Arlian L.G., Neal J.S., Morgan M.S., et al. Reducing relative humidity is a practical way to control dust mites and their allergens in homes in temperate climates. J Allergy Clin Immunol. 107:2001;99-104.
117. Mar A., Tam M., Jolley D., Marks R. The cumulative incidence of atopic dermatitis in the first 12 months among Chinese, Vietnamese, and Caucasian infants born in Melbourne, Australia. J Am Acad Dermatol. 40:1999;597-602.
118. Denda M., Sato J., Masuda Y., et al. Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol. 111:1998;858-863.
119. Wood L.C., Jackson S.M., Elias P.M., Grunfeld C., Feingold K.R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 90:1992;482-487.
120. Wood L.C., Elias P.M., Calhoun C., et al. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol. 106:1996;397-403.
121. Gfesser M., Rakoski J., Ring J. The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema. Br J Dermatol. 135:1996;560-565.
122. Taieb A. Hypothesis from epidermal barrier dysfunction to atopic disorders . Contact Dermatitis. 41:1999;177-180.
123. Vanselow N.A., Yamate M., Adams M.S., Callies Q. The increased prevalence of allergic disease in anhidrotic congenital ectodermal dysplasia. J Allergy. 45:1970;302-309.
124. Tupker R.A., Pinnagoda J., Coenraads P.J., Nater J.P. Susceptibility to irritants role of barrier function, skin dryness and history of atopic dermatitis . Br J Dermatol. 123:1990;199-205.
125. Spitz J.L. Genodermatosis. 1996;214-215 Williams and Wilkins, Baltimore.